| Truman Stephen Shaddox, MD | |
|
12 E Appleby Rd, Ste 101, Fayetteville, AR 72703-3901 | |
| (479) 463-4444 | |
| (479) 463-4499 |
| Full Name | Truman Stephen Shaddox |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Location | 12 E Appleby Rd, Fayetteville, Arkansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649236951 | NPI | - | NPPES |
| 106393001 | Medicaid | AR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | C-4757 (Arkansas) | Primary |
| Entity Name | Washington Regional Medical System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699731208 PECOS PAC ID: 8820995434 Enrollment ID: O20050912001236 |
News Archive
A new genetic biomarker that indicates an increased risk for developing breast cancer can be found in an individual's "junk" (non-coding) DNA, according to a new study featuring work from researchers at the Virginia Bioinformatics Institute (VBI) at Virginia Tech and their colleagues.
A new study published on the preprint server medRxiv in June 2020 shows that variants in the ACE2 gene which encodes the enzyme receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19 disease, are linked to the risk of severe disease.
Currently, with a pre-malignant breast cancer diagnosis from a biopsy, there are three options: observation, chemoprevention or surgery, all of which require a patient to make decisions while operating from a place of fear and unknown outcomes.
Three U.S. senators seeking to speed up review times for medical devices have proposed two new bills for advisers to the Food and Drug Administration (FDA). The measure would reverse 2007 legislation that barred experts who had financial ties to a company or its competitor from serving on an advisory panel without a waiver. There is also a limit on the number of waivers that keeps decreasing.
As scientists continue to search for effective antidotes to direct and indirect damage caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a new preprint research paper posted to the bioRxiv* server demonstrates the potential of cannabinoid receptor agonists to alleviate myocardial damage in this condition even in the absence of any inhibitory effect on viral infection as such.
› Verified 1 days ago
| Entity Name | Washington Regional Medical System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205073657 PECOS PAC ID: 8820995434 Enrollment ID: O20090420000382 |
News Archive
A new genetic biomarker that indicates an increased risk for developing breast cancer can be found in an individual's "junk" (non-coding) DNA, according to a new study featuring work from researchers at the Virginia Bioinformatics Institute (VBI) at Virginia Tech and their colleagues.
A new study published on the preprint server medRxiv in June 2020 shows that variants in the ACE2 gene which encodes the enzyme receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19 disease, are linked to the risk of severe disease.
Currently, with a pre-malignant breast cancer diagnosis from a biopsy, there are three options: observation, chemoprevention or surgery, all of which require a patient to make decisions while operating from a place of fear and unknown outcomes.
Three U.S. senators seeking to speed up review times for medical devices have proposed two new bills for advisers to the Food and Drug Administration (FDA). The measure would reverse 2007 legislation that barred experts who had financial ties to a company or its competitor from serving on an advisory panel without a waiver. There is also a limit on the number of waivers that keeps decreasing.
As scientists continue to search for effective antidotes to direct and indirect damage caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a new preprint research paper posted to the bioRxiv* server demonstrates the potential of cannabinoid receptor agonists to alleviate myocardial damage in this condition even in the absence of any inhibitory effect on viral infection as such.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Truman Stephen Shaddox, MD 12 E Appleby Rd, Ste 101, Fayetteville, AR 72703-3901 Ph: (479) 463-4444 | Truman Stephen Shaddox, MD 12 E Appleby Rd, Ste 101, Fayetteville, AR 72703-3901 Ph: (479) 463-4444 |
News Archive
A new genetic biomarker that indicates an increased risk for developing breast cancer can be found in an individual's "junk" (non-coding) DNA, according to a new study featuring work from researchers at the Virginia Bioinformatics Institute (VBI) at Virginia Tech and their colleagues.
A new study published on the preprint server medRxiv in June 2020 shows that variants in the ACE2 gene which encodes the enzyme receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19 disease, are linked to the risk of severe disease.
Currently, with a pre-malignant breast cancer diagnosis from a biopsy, there are three options: observation, chemoprevention or surgery, all of which require a patient to make decisions while operating from a place of fear and unknown outcomes.
Three U.S. senators seeking to speed up review times for medical devices have proposed two new bills for advisers to the Food and Drug Administration (FDA). The measure would reverse 2007 legislation that barred experts who had financial ties to a company or its competitor from serving on an advisory panel without a waiver. There is also a limit on the number of waivers that keeps decreasing.
As scientists continue to search for effective antidotes to direct and indirect damage caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a new preprint research paper posted to the bioRxiv* server demonstrates the potential of cannabinoid receptor agonists to alleviate myocardial damage in this condition even in the absence of any inhibitory effect on viral infection as such.
› Verified 1 days ago
Richard D Mcwhorter, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2 East Appleby Rd., Suite 201, Fayetteville, AR 72703 Phone: 479-404-1100 Fax: 479-404-1101 | |
William Vernon Fairchild, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 1100 N College Ave, Fayetteville, AR 72703 Phone: 479-443-4301 | |
Dr. Aleksandar Cody Blubaum, MD Urology Medicare: Medicare Enrolled Practice Location: 3 E Appleby Rd Ste 201, Fayetteville, AR 72703 Phone: 479-404-1100 | |
Charles Mark Jackson, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 3 E Appleby Rd Ste 201, Fayetteville, AR 72703 Phone: 479-404-1100 Fax: 479-404-1101 | |
Dr. Issam Toufic Shalhoub, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 1100 N College Ave, Fayetteville, AR 72703 Phone: 479-443-4301 | |
Michael R Wilson, M.D. Urology Medicare: Medicare Enrolled Practice Location: 1300 E Zion Rd, Fayetteville, AR 72703 Phone: 479-521-8980 Fax: 479-521-8982 |